Kinnate Biopharma
Stock Forecast, Prediction & Price Target

Kinnate Biopharma Financial Estimates

Kinnate Biopharma Revenue Estimates

Kinnate Biopharma EBITDA Estimates

Kinnate Biopharma Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $61.33M
Low: $61.33M
High: $61.33M
avg. 0%
Avg: $197.05M
Low: $197.05M
High: $197.05M
avg. 221.28%
Net Income
 
% change YoY
$-89.41M
 
N/A
$-114.02M
 
-27.51%
$-112.64M
 
1.20%
Avg: $-52.75M
Low: $-44.24M
High: $-33.06M
avg. 53.16%
Avg: $-68.90M
Low: $-45.17M
High: $-31.20M
avg. -30.60%
Avg: $-51.69M
Low: $-51.69M
High: $-51.69M
avg. 24.97%
Avg: $-17.69M
Low: $-17.69M
High: $-17.69M
avg. 65.76%
EBITDA
 
% change YoY
$-89.98M
 
N/A
$-117.91M
 
-31.03%
$-118.20M
 
-0.24%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$2.05
 
N/A
-$2.59
 
-26.34%
-$2.42
 
6.56%
Avg: -$0.86
Low: -$0.95
High: -$0.71
avg. 64.46%
Avg: -$0.82
Low: -$0.97
High: -$0.67
avg. 4.65%
Avg: -$1.11
Low: -$1.11
High: -$1.11
avg. -35.36%
Avg: -$0.38
Low: -$0.38
High: -$0.38
avg. 65.76%
Operating Expenses
 
% change YoY
$90.11M
 
N/A
$118.52M
 
31.52%
$118.20M
 
-0.26%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Kinnate Biopharma stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 28.32% in 2025-2028.

We have gathered data from 3 analysts. Their low estimate is -44.24M, average is -52.75M and high is -33.06M.

What is Kinnate Biopharma stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 55.32% in 2025-2028.

We have gathered data from 3 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Kinnate Biopharma stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 24.87% in 2025-2028.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.95, average is -$0.86 and high is $-0.71.

What is the best performing analyst?

In the last twelve months analysts have been covering Kinnate Biopharma stock. The most successful analyst is Christopher Raymond.